On this occasion, Kolinpharma presented many new products, such as the new Neurological Line that joins the two historical lines, the Osteo-articular and the Uro-gynecological, but not only that, in this showcase it launched the newly born Immunological Line, thus further expanding the product portfolio.

Kolinpharma also celebrated its first 11 years: the confirmation of excellence, active listening, innovation and advanced technologies, which also lead to a further milestone, that of recognized patents, which today amount to 51 patents. Another element of pride, because they are the result of years of in-depth studies and the company's desire to look at innovation, to fill the unsatisfied or unexpressed needs of "our" Specialist Doctors. And representing this, Kolinpharma can boast the excellent results it is obtaining, especially with one of its products on the list, MILESAX®, a nutraceutical with a fast muscle relaxant action, which has been the company's sales blockbuster since 2017 and also the leader in the reference market since 2021.

Kolinpharma is also a B Corp company: we are attentive to sustainability and we are concretely committed to reducing the CO₂ produced.

Kolinpharma, which year after year consolidates its presence in Italy, is ready to bring its Know-How made of passion for Research and Innovation, even beyond national borders.

From fruitful meetings to new connections, participation in CPHI was an extraordinary opportunity to strengthen existing partnerships and explore collaborations for the future.

A heartfelt thanks to our current and potential partners for the shared vision and the opportunities to grow together. We are more than motivated to promote mutual success in the months to come.